Systems for therapeutic angiogenesis in tissue engineering

World Journal of Urology

Volumn 18, Issue 1, 2000, Pages 10-18

  Soker, Shay ^a   Machado, Marcos ^a   Atala, Anthony ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR;

ANGIOGENESIS; ARTICLE; BIOMEDICAL ENGINEERING; CYTOLOGY; ENDOTHELIUM; HUMAN; ISCHEMIA; METHODOLOGY;

ANGIOGENESIS INDUCING AGENTS; BIOMEDICAL ENGINEERING; ENDOTHELIUM; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0034136030     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007070     Document Type: Article

References (98)

1. Abraham JA, Mergia A, Whang JL, Tumolo A, Friedman J, Hjerrild KA, Gospodarowicz D, Fiddes JC (1986) Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233: 545-545
2. 165 gene transfer. Circulation 94: 3291-3302
3. Asahara T, Murohara T, Sullivan A, Silver M, van-der-Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967
4. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972
5. Atala A (1999) Future perspectives in reconstructive surgery using tissue engineering. Urol Clin North Am 26: 157-165
6. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P (1992) Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 19: 181-191
7. Baird A, Bohlen P (1991) Fibroblast growth factors. In: Sporn MB, Roberts AB (eds) Peptide growth factors and their receptors, vol 1. Springer. New York, pp 369-4118
8. Basilico C, Moscatelli D (1992) The FGF family of growth factors and oncogenes. Adv Cancer Res 59: 115-165
9. Battegay EJ (1995) Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 73: 333-346
10. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM (1994) Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vase Surg 21: 314-325
11. Bikfalvi A, Klein S, Pintucci G, Rifkin DB (1997) Biological roles of fibroblast growth factor-2. Endocr Rev 18: 26-45
12. Breier G, Albrecht U, Sterrer S, Risau W (1992) Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114: 521-532
13. Burgess WH, Mehlman T, Marshak DR, Fraser BA, Maciag T (1986) Structural evidence that endothelial cell growth factor beta is the precursor of both endothelial cell growth factor alpha and acidic fibroblast growth factor. Proc Natl Acad Sci USA 83: 7216-7220
14. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439
15. 188. Nat Med 5: 495-502
16. Darland DC, D'Amore PA (1999) Blood vessel maturation: vascular development comes of age. J Clin Invest 103: 157- 158
17. Davis S, Yancopoulos GD (1999) The angiopoietins: yin and yang in angiogenesis. Curr Top Microbiol Immunol 237: 173-185
18. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991
19. Drake CJ, Hungerford JE, Little CD (1998) Morphogenesis of the first blood vessels. Ann NY Acad Sci 857: 155-179
20. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ, Van de Water L, Senger DR (1991) Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 174: 1275-1278
21. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039
22. Eiselt P, Kim B-S, Chacko B, Isenberg B, Peters MC, Greene KG, Roland WD, Loebsack AB, Burg KJ, Culberson C, Halberstadt CR, Holder WD, Mooney DJ (1998) Development of technologies aiding large-tissue engineering. Biotechnol Prog 14: 134-140
23. Ferrara N, Davis-Smith T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25
24. Ferrara N, Heinsohn H, Walder CE, Bunting S, Thomas GR (1995) The regulation of blood vessel growth by vascular endothelial growth factor. Ann NY Acad Sci 752: 246-256
25. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442
26. Finnerty H, Kelleher K, Morris GE, Bean K, Merberg DM, Kriz R, Morris JC, Sookdeo H, Turner KJ, Wood CR (1993) Molecular cloning of murine FLT and FLT4. Oncogene 8: 2293-2298
27. Flamme I, Frolich T, Risau W (1997) Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 173: 206-210
28. Folkman J (1992) The role of angiogenesis in tumor growth. Semin Cancer Biol 3: 65-71
29. Folkman J (1995) Angiogenesis inhibitors generated by tumors. Mol Med 1: 120-122
30. Folkman J (1995) Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-1763
31. Folkman J (1996) Fighting cancer by attacking its blood supply. Sci Am 275: 150-154
32. Folkman J (1997) Angiogenesis and angiogenesis inhibition: an overview. EXS 79: 1-8
33. Folkman J, Brem H (1992) Angiogenesis and inflammation. In: Gallin JI, Goldstein IM, Snyderman R(eds) Inflammation: basic principles and clinical correlates. Raven, New York, pp 821 -839
34. Folkman J, D'Amore PA (1996) Blood vessel formation: what is its molecular basis? Cell 87: 1153-1155
35. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267: 10931-10934
36. Fong GH, Rossant J, Gertsenstein M, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70
37. Fontaine M, Schloo B, Jenkins R, Uyama S, Hansen L, Vacanti JP (1995) Human hepatocyte isolation and transplantation into an athymic rat, using prevascularized cell polymer constructs. J Pediatr Surg 30: 50-60
38. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270: 12607-12613
39. Gilbert JC, Takada T, Stein JE, Langer R, Vacanti JP (1993) Cell transplantation of genetically altered cells on biodegradable polymer scaffolds in syngeneic rats. Transplantation 56: 423-427
40. Hanahan D (1997) Signaling vascular morphogenesis and maintenance. Science 277: 48-50
41. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364
42. Henry TD (1999) Therapeutic angiogencsis. BMJ 318: 1536-1539
43. Holder WD, Gruber HE, Roland WD, Moore AL, Culberson CR, Loebsack AB, Burg KJL, Mooney DJ (1997) Increases in vascularization and heterogeneity of vascular structures occurring in polyglycolide matrices containing aortic endothelial cells implanted in the rat. Tissue Eng 3: 149- 160
44. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267: 26031-26037
45. Hubbel JA (1995) Biomaterials in tissue engineering. Biotechnology 13: 565-576
46. Isner JM (1998) Vascular endothelial growth factor: gene therapy and therapeutic angiogenesis. Am J Cardiol 82: 63S-64S
47. Isner JM, Asahara T (1998) Therapeutic angiogenesis. Front Biosci 3: 49-69
48. Isner JM, Losordo DW (1999) Therapeutic angiogenesis for heart failure. Nat Med 5: 491-492
49. 165 in patient with ischaemic limb. Lancet 348: 370-374
50. Jain RK, Schienger K, Hockel M, Yuan F (1997) Quantitative angiogenesis assays: progress and problems. Nat Med 3: 1203-1208
51. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309-1312
52. Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ (1996) A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 37: 1625-1632
53. Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R, Ferrara N (1996) The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271: 7788-7795
54. King GL, Brownlee M (1996) The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 25: 255-270
55. Klagsbrun M, Baird A (1991) A dual receptor system is required for basic fibroblast growth factor activity. Cell 67: 229-231
56. Klagsbrun M, Soker S (1993) VEGF/VPF: the angiogenic factor found? Curr Biol 3: 699-702
57. Levy AP, Levy NS, Goldberg MA (1996) Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J Biol Chem 271: 25492-25497
58. Levy AP, Levy NS, Goldberg MA (1996) Post-transcriptional regulation of vascular endothelial growth factor by hvpoxia. J Biol Chem 271: 2746-2753
59. Machluf M, Atala A (1998) Tissue engineering: emerging concepts. Graft 1: 31-37
60. Mikos AG SG, Leite SM, Vacanti JP, Langer R (1993) Prevascularization of porous biodegradable polymers. Biotechnol Bioeng 42: 716-723
61. Mooney DJ, Mikos AG (1999) Growing new orcans. Sci Am 280: 60-65
62. Nguyen M, Shing Y, Folkman J (1994) Quantitation of an giogenesis and antiangiogenesis in the chick embryo chor ioallantoic membrane. Microvasc Res 47: 31-40
63. Noishiki Y, Tomizawa Y, Yamane Y, Matsumoto A (1996) Autocrine angiogenic vascular prosthesis with bone marrow transplantation. Nat Med 2: 90-93
64. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328
65. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285
66. Park HJ, Yoo JJ, T, KR, Moreland RB, Krane RJ, Atala A (1999) Reconstruction of human corpus cavernosum smooth muscle and endothelial cells in vivo. J Urol 162: 1106-1109
67. Park JE, Keller GA, Ferrara N (1993) The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4: 1317-1326
68. Pepper MS (1997) Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 81: 21-443
69. Plate KH, Breier G, Millauer B, Ullrich A, Risau W (1993) Upregulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53: 5822-5827
70. Raines EW, Bowen-Pope DF, Ross R (1991) Platelet-derived growth factor. In: Sporn MB, Roberts AB (eds) Peptide growth factors and their receptors, vol 1. Springer, New York, pp 173-262
71. Risau W (1997) Mechanisms of angiogenesis. Nature 386: 671-674
72. Risau W, Flamme I (1995) Vasculogenesis. Annu Rev Cell Dev Biol 11: 73-91
73. Rivard A, Isner JM (1998) Angiogenesis and vasculogenesis in treatment of cardiovascular disease. Mol Med 4: 429-440
74. Rogelj S, Klagsbrun M, Atzmon R, Kurokawa M, Haimovitz A, Fuks Z, Vlodavsky I (1989) Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells. J Cell Biol 109: 823-831
75. Rotter N, Aigner J, Naumann A, Planck H, Hammer C, Burmester G, Sittinger M (1998) Cartilage reconstruction in head and neck surgery: comparison of resorbable polymer scaffolds for tissue engineering of human septal cartilage. J Biomed Mater Res 42: 347-356
76. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74
77. Schumacher B, Pecher P, Specht BU von, Stegmann T (1998) Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 97: 645-650
78. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66
79. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM (19987) Engineering the tissue which encapsulates subcutane-ous implants. III. Effective tissue response times. J Biomed Mater Res 40: 598-605
80. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (fit) closely related to the fms family. Oncogene 5: 519-524
81. Shima DT, Adamis AP, Ferrara N, Yeo KT, Yeo TK, Allende R, Folkman J, D'Amore PA (1995) Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med 1: 182-193
82. Shweiki D, Itin A, Softer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845
83. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E (1993) Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91: 2235-2243
84. 165 via its exon 7-encoded domain. J Biol Chem 271: 5761-5767
85. 165. J Biol Chem 272: 31582-31588
86. Soker S, Takashima S, Hua-Quan M, Neufeld G, Klagsbrun M (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735-745
87. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM (1998) VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 2: 549-558
88. Takagi S, Hirata T, Agata K, Mochii M, Eguchi G, Fujisawa H (1991) The A5 antigen, a candidate for the neuronal recognition molecule, has homologies to complement components and coagulation factors. Neuron 7: 295-307
89. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438
90. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM (1994) Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93: 662-670
91. Takeshita S, Tsurumi Y, Couffinahl T, Asahara T, Bauters C, Symes J, Ferrara N, Isner JM (1996) Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 75: 487-501
92. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187: 1579-1586
93. Veikkola T, Alitalo K (1999) VEGFs, receptors and angiogenesis. Semin Cancer Biol 9: 211-220
94. Vernon RB, Sage EH (1999) A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices. Microvasc Res 57: 118-133
95. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, Ito H (1992) Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257: 1401-1403
96. Yancopoulos GD, Klagsbrun M, Folkman J (1998) Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell 93: 661-664
97. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM (1991) Cell surface, heparin-like molecules are required for binding basic fibroblast growth factor to its high affinity receptors. Cell 64: 841-848
98. Zawicki DF, Jain RK, Schmid-Schoenbein GW, Chien S (1981) Dynamics of neovascularization in normal tissue. Microvasc Res 21: 27-47